Drug intelligence / Profile preview

somatropin

Development stage
Approved
Lead developer
Genentech
Modality
Recombinant Proteins and Enzymes
Administration
Subcutaneous, Intramuscular
01

Overview

Somatropin is a recombinant form of human growth hormone (hGH) produced using recombinant DNA technology. It acts as a replacement therapy for endogenous growth hormone in individuals with deficiency or failure to produce sufficient amounts. Somatropin binds to the growth hormone receptor and stimulates production of insulin-like growth factor 1 (IGF-1), promoting linear bone and tissue growth in children and metabolic effects in adults. It is primarily indicated for pediatric and adult patients with growth hormone deficiency but is also used for conditions such as Turner syndrome, Prader-Willi syndrome (PWS), Noonan syndrome, chronic kidney disease-related short stature in children prior to puberty or renal transplantation; idiopathic short stature; cachexia associated with AIDS; short bowel syndrome; burns with nitrogen retention needs; hypopituitarism; SHOX deficiency; and unintentional weight loss[1][3][4][5].

Brand names
GenotropinNorditropinOmnitropeHumatropeNorditropin FlexProAccretropinGenotropin MiniquickNutropinNutropin AQ NuSpin 10Nutropin AQ NuSpin 5Nutropin AQ PenSaizenSerostimZomactonZorbtive
Other names
recombinant human growth hormone
02

Targets

GHR (Growth hormone receptor)

Beyond the preview

Go deeper on somatropin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on somatropin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call